SCHEMBL4570823

SCHEMBL4570823

COCc1cc(C)c(C)c(C)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.36
HSD17B10 Q99714 2/20 0.36
TUBB1 Q9H4B7 1/20 0.33
MAPT P10636 2/20 0.32
LMNA P02545 2/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
CYP3A4 P08684 1/20 0.32
CRHR1 P34998 1/20 0.32
TACR1 P25103 2/20 0.32
ALDH1A1 P00352 4/20 0.32
GAA P10253 1/20 0.32
ALOX15 P16050 1/20 0.32
APOBEC3G Q9HC16 1/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.31
PRKCG P05129 1/20 0.31
PRKCA P17252 1/20 0.31
APEX1 P27695 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14547433 0.84 CRHR1 (0.34) HPGDHSD17B10MAPTCRHR1ALDH1A1
SCHEMBL13384685 0.84 CYP3A4 (0.45) HPGDHSD17B10TUBB1MAPTCYP3A4
SCHEMBL4380347 0.81 SHBG (0.44) HPGDHSD17B10MAPTLMNAL3MBTL1
SCHEMBL23743654 0.80 ALDH1A1 (0.44) TUBB1MAPTLMNANPC1CYP3A4
SCHEMBL14853199 0.80 HPGD (0.34) HPGDHSD17B10MAPTLMNACRHR1
SCHEMBL9191718 0.80 CA1 (0.46) MAPTL3MBTL1CYP3A4ALDH1A1GAA
SCHEMBL3504510 0.80 ALDH1A1 (0.46) HPGDHSD17B10LMNACYP3A4ALDH1A1
SCHEMBL3624689 0.80 PRKCE (0.37) MAPTLMNAL3MBTL1ALDH1A1MEN1
SCHEMBL16597205 0.77 ALDH1A1 (0.39) HPGDHSD17B10MAPTLMNAL3MBTL1
SCHEMBL8728579 0.77 RAPGEF4 (0.30) RAPGEF4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130296352-A1 PYRAZOLOQUINOLINE DERIVATIVES EISAI R&D MANAGEMENT CO., LTD. (JP) 2013-11-07 US disclosed
US-8563565-B2 Pyrazoloquinoline derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2013-10-22 US disclosed
US-20130143907-A1 PYRAZOLOQUINOLINE DERIVATIVES EISAI R&D MANAGEMENT CO., LTD. (JP) 2013-06-06 US disclosed
US-8173628-B2 Therapy for hormone sensitive diseases; side effect reduction; anticancer agents; osteoporosis; endometriosis; benign prostatic hyperplasia; cardiovascular disorders; acne NORTHEASTERN UNIVERSITY (US) 2012-05-08 US disclosed
US-8173628-B2 Therapy for hormone sensitive diseases; side effect reduction; anticancer agents; osteoporosis; endometriosis; benign prostatic hyperplasia; cardiovascular disorders; acne NORTHEASTERN UNIVERSITY (US) 2012-05-08 US disclosed
US-8124294-B2 Polymer electrolyte membrane comprising inorganic nanoparticle bonded with proton-conducting group and solid acid, fuel cell including the same, and method of preparing the polymer electrolyte membrane SAMSUNG SDI CO., LTD. (KR) 2012-02-28 US disclosed
US-8119833-B2 Dendrimer solid acid and polymer electrolyte membrane including the same SAMSUNG SDI CO., LTD. (KR) 2012-02-21 US disclosed
US-8049033-B2 Dendrimer solid acid and polymer electrolyte membrane including the same SAMSUNG SDI CO., LTD. (KR) 2011-11-01 US disclosed
US-20110262833-A1 DENDRIMER SOLID ACID AND POLYMER ELECTROLYTE MEMBRANE INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2011-10-27 US disclosed
US-20080166301-A1 Steroidal antiestrogens and antiandrogens and uses thereof NORTHEASTERN UNIVERSITY 2008-07-10 US disclosed
US-20080166301-A1 Steroidal antiestrogens and antiandrogens and uses thereof NORTHEASTERN UNIVERSITY 2008-07-10 US disclosed
US-20080085441-A1 POLYMER ELECTROLYTE MEMBRANE COMPRISING INORGANIC NANOPARTICLE BONDED WITH PROTON-CONDUCTING GROUP AND SOLID ACID, FUEL CELL INCLUDING THE SAME, AND METHOD OF PREPARING THE POLYMER ELECTROLYTE MEMBRANE SAMSUNG SDI CO., LTD. (KR) 2008-04-10 US disclosed
US-20070092778-A1 Oligomer solid acid and polymer electrolyte membrane including the same SAMSUNG SDI CO., LTD. (KR) 2007-04-26 US disclosed
US-20070092779-A1 Dendrimer solid acid and polymer electrolyte membrane including the same SAMSUNG SDI CO., LTD. (KR) 2007-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130143907-A1 PYRAZOLOQUINOLINE DERIVATIVES PDE2A, PDE3A, PDE3B HPGD 256/4885HSD17B10 803/4885TUBB1 3186/4885
US-20080166301-A1 Steroidal antiestrogens and antiandrogens and uses thereof NR5A1, SHBG, AR HPGD 418/4885HSD17B10 89/4885TUBB1 4399/4885
US-20130296352-A1 PYRAZOLOQUINOLINE DERIVATIVES PDE2A, PDE3A, PDE3B HPGD 256/4885HSD17B10 803/4885TUBB1 3186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.